Abstract
Brain abscess has an incidence of 1 per 100,000 in developed countries and a mortality rate of 10%. Cerebral infections with Nocardia farcinica have a mortality of up to 90%. Nocardial species are important pathogens in immunocompromised hosts, but infections in immunocompetent patients are extremely rare. We report a case of primary brain abscess with N. farcinica in a patient without immunosuppression, which was treated with surgery and a one-year course of oral moxifloxacin.
MeSH terms
-
Anti-Infective Agents / therapeutic use
-
Aza Compounds / therapeutic use
-
Brain Abscess / diagnostic imaging
-
Brain Abscess / drug therapy
-
Brain Abscess / microbiology*
-
Fluoroquinolones
-
Humans
-
Immunocompetence
-
Male
-
Middle Aged
-
Moxifloxacin
-
Nocardia / isolation & purification
-
Nocardia Infections / complications*
-
Nocardia Infections / drug therapy
-
Quinolines / therapeutic use
-
Radiography
Substances
-
Anti-Infective Agents
-
Aza Compounds
-
Fluoroquinolones
-
Quinolines
-
Moxifloxacin